NASDAQ:AGRX - Agile Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.8910 +0.11 (+14.08 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$0.8910
Today's Range$0.78 - $0.8950
52-Week Range$0.23 - $3.92
Volume693,873 shs
Average Volume201,967 shs
Market Capitalization$26.81 million
P/E Ratio-0.98
Dividend YieldN/A
Beta-0.16

Headlines

Agile Therapeutics (NASDAQ AGRX) News Headlines

Source:
DateHeadline
The Daily Biotech Pulse: Agile (NASDAQ:AGRX) Gives Regulatory Update On Contraceptive Patch, Advaxis (NASDAQ:ADXS) Misses Estimates, Ocular (NASDAQ:OCUL) Submits sNDA - BenzingaThe Daily Biotech Pulse: Agile (NASDAQ:AGRX) Gives Regulatory Update On Contraceptive Patch, Advaxis (NASDAQ:ADXS) Misses Estimates, Ocular (NASDAQ:OCUL) Submits sNDA - Benzinga
www.benzinga.com - January 12 at 5:34 PM
AGRX: Twirla® Adhesion Study Underway; NDA Resubmission in 2Q19…AGRX: Twirla® Adhesion Study Underway; NDA Resubmission in 2Q19…
finance.yahoo.com - January 11 at 6:40 PM
Agile Therapeutics (AGRX) Given "Buy" Rating at HC WainwrightAgile Therapeutics (AGRX) Given "Buy" Rating at HC Wainwright
www.americanbankingnews.com - January 11 at 9:01 AM
Agile Therapeutics advancing Twirla, to refile U.S. marketing application next quarterAgile Therapeutics advancing Twirla, to refile U.S. marketing application next quarter
seekingalpha.com - January 10 at 6:06 PM
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash GuidanceAgile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
finance.yahoo.com - January 10 at 6:06 PM
 Brokerages Expect Agile Therapeutics Inc (AGRX) Will Announce Earnings of -$0.11 Per Share Brokerages Expect Agile Therapeutics Inc (AGRX) Will Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - January 2 at 1:16 PM
Agile Therapeutics Inc (AGRX) Sees Significant Decrease in Short InterestAgile Therapeutics Inc (AGRX) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - December 31 at 1:42 AM
Agile Therapeutics Inc (AGRX) Given Average Rating of "Buy" by AnalystsAgile Therapeutics Inc (AGRX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 25 at 5:33 AM
Agile Therapeutics to Present at Biotech Showcase 2019Agile Therapeutics to Present at Biotech Showcase 2019
finance.yahoo.com - December 18 at 8:20 AM
Agile meets with FDA on design of study to support Twirla refilingAgile meets with FDA on design of study to support Twirla refiling
seekingalpha.com - December 13 at 5:42 PM
Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
finance.yahoo.com - December 13 at 5:42 PM
Wainwright bullish on Agile Therapeutics, sees 270% upsideWainwright bullish on Agile Therapeutics, sees 270% upside
seekingalpha.com - November 29 at 5:46 PM
Agile Therapeutics Inc (NASDAQ:AGRX): Are Analysts Optimistic?Agile Therapeutics Inc (NASDAQ:AGRX): Are Analysts Optimistic?
finance.yahoo.com - November 13 at 5:12 PM
AGRX: Awaiting Details of Adhesion Study for Twirla®…AGRX: Awaiting Details of Adhesion Study for Twirla®…
finance.yahoo.com - November 5 at 5:24 PM
Form 10-Q AGILE THERAPEUTICS INC For: Sep 30Form 10-Q AGILE THERAPEUTICS INC For: Sep 30
www.streetinsider.com - November 4 at 8:22 AM
Agile Therapeutics: 3Q Earnings SnapshotAgile Therapeutics: 3Q Earnings Snapshot
finance.yahoo.com - November 2 at 8:14 AM
Agile Therapeutics Reports Third Quarter 2018 Financial ResultsAgile Therapeutics Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 1 at 6:04 PM
Late-stage data support use of Agiles Twirla in overweight women; shares up 8% premarketLate-stage data support use of Agile's Twirla in overweight women; shares up 8% premarket
seekingalpha.com - October 25 at 5:32 PM
Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the ...Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the ...
globenewswire.com - October 25 at 8:19 AM
Agile Therapeutics (AGRX) Highlights Additional Analyses of AG200-15 (Twirla) Phase 3 SECURE Study ResultsAgile Therapeutics (AGRX) Highlights Additional Analyses of AG200-15 (Twirla) Phase 3 SECURE Study Results
www.streetinsider.com - October 24 at 5:07 PM
Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)
finance.yahoo.com - October 24 at 8:20 AM
Agile Therapeutics Gets a Path Forward for Twirla, Analysts Review and TargetAgile Therapeutics Gets a Path Forward for Twirla, Analysts Review and Target
finance.yahoo.com - October 22 at 5:22 PM
AGRX: FDA Provides Path to NDA Resubmission for Twirla®…AGRX: FDA Provides Path to NDA Resubmission for Twirla®…
finance.yahoo.com - October 10 at 5:02 PM
Todays Research Reports on Trending Tickers: Agile Therapeutics and Horizon PharmaToday's Research Reports on Trending Tickers: Agile Therapeutics and Horizon Pharma
finance.yahoo.com - October 10 at 5:02 PM
Agile Therapeutics (AGRX) Completes Formal Dispute Resolution Process with the FDAAgile Therapeutics (AGRX) Completes Formal Dispute Resolution Process with the FDA
www.streetinsider.com - October 10 at 8:17 AM
Agile Therapeutics up 62% on development path for TwirlaAgile Therapeutics up 62% on development path for Twirla
seekingalpha.com - October 9 at 4:57 PM
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDAAgile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
finance.yahoo.com - October 9 at 8:23 AM
AGRX Sep 2018 7.500 callAGRX Sep 2018 7.500 call
finance.yahoo.com - September 18 at 4:59 PM
Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?
finance.yahoo.com - September 14 at 5:00 PM
Agile Therapeutics up 55% premarketAgile Therapeutics up 55% premarket
seekingalpha.com - September 11 at 4:55 PM
Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance IndicationsConsolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications
finance.yahoo.com - August 29 at 8:27 AM
AGRX: Formal Dispute Resolution Continues to Office of New Drugs…AGRX: Formal Dispute Resolution Continues to Office of New Drugs…
finance.yahoo.com - August 9 at 6:03 PM
Agile Therapeutics Reports Second Quarter 2018 Financial ResultsAgile Therapeutics Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 3 at 8:23 AM
Agile Therapeutics: 2Q Earnings SnapshotAgile Therapeutics: 2Q Earnings Snapshot
finance.yahoo.com - August 3 at 8:23 AM
Complimentary Technical Snapshots on Akorn and Three More Generic Drugs StocksComplimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks
finance.yahoo.com - July 31 at 8:29 AM
Pre-Open Movers 07/25: (TORC) (NVRO) (IRBT) Higher; (AGRX) (AOBC) (FCAU) Lower (more...)Pre-Open Movers 07/25: (TORC) (NVRO) (IRBT) Higher; (AGRX) (AOBC) (FCAU) Lower (more...)
www.streetinsider.com - July 26 at 8:17 AM
Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares PlungeMid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Plunge
www.nasdaq.com - July 26 at 8:17 AM
FDA rejects Agiles appeal of Twirla CRL; shares down 41% after hoursFDA rejects Agile's appeal of Twirla CRL; shares down 41% after hours
seekingalpha.com - July 25 at 8:19 AM
FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution RequestFDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
finance.yahoo.com - July 24 at 4:47 PM
Form 8-K AGILE THERAPEUTICS INC For: Jul 02Form 8-K AGILE THERAPEUTICS INC For: Jul 02
www.streetinsider.com - July 10 at 4:58 PM
Benzingas Daily Biotech Pulse: Titans Parkinsons Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% PremiumBenzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium
www.msn.com - July 3 at 8:49 AM
Free Technical Research on Akorn and Three More Generic Drugs EquitiesFree Technical Research on Akorn and Three More Generic Drugs Equities
finance.yahoo.com - June 25 at 8:39 AM
AGRX: Files Formal Dispute Resolution with the FDAAGRX: Files Formal Dispute Resolution with the FDA
finance.yahoo.com - June 8 at 5:31 PM
Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash GuidanceAgile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance
finance.yahoo.com - June 7 at 5:25 PM
AGRX: Determining a Path Forward Following Receipt of Meeting MinutesAGRX: Determining a Path Forward Following Receipt of Meeting Minutes
finance.yahoo.com - May 22 at 5:09 PM
Agile Therapeutics Is Attempting A Hail Mary Play With A Formal Dispute ResolutionAgile Therapeutics Is Attempting A Hail Mary Play With A Formal Dispute Resolution
seekingalpha.com - May 21 at 5:10 PM
Today’s Research Reports on Stocks to Watch: Agile Therapeutics and Arrowhead PharmaceuticalsToday’s Research Reports on Stocks to Watch: Agile Therapeutics and Arrowhead Pharmaceuticals
finance.yahoo.com - May 21 at 8:15 AM
Agile Therapeutics (AGRX) Announces Regulatory Update on Twirla; FDA Continues to have Significant ConcernsAgile Therapeutics (AGRX) Announces Regulatory Update on Twirla; FDA Continues to have Significant Concerns
www.streetinsider.com - May 18 at 6:01 PM
Agile Therapeutics down 76% on additional work needed for U.S. approval of TwirlaAgile Therapeutics down 76% on additional work needed for U.S. approval of Twirla
seekingalpha.com - May 18 at 6:01 PM
Agile Therapeutics sinks after FDA feedback on contraceptiveAgile Therapeutics sinks after FDA feedback on contraceptive
finance.yahoo.com - May 18 at 6:01 PM
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel